Pacritinib Shows Consistent Efficacy for Spleen, Symptom Response in Myelofibrosis

By Cecilia Brown, Prithviraj Bose, MD - Last Updated: September 5, 2023

Prithviraj Bose, MD, of the University of Texas MD Anderson Cancer Center, discusses his 2023 American Society of Clinical Oncology Annual Meeting abstract titled “Consistency of pacritinib for spleen and symptom reduction in patients with myelofibrosis regardless of cytopenias.”

Advertisement

Post Tags:MFASCO23
Advertisement
Advertisement
Advertisement
Editorial Board